Dr. Eli Daniel Scher, DO

Dr. Scher practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Scher's NPI, 1477949782, was assigned on April 13, 2015. Dr. Scher holds Ohio license 34.014670.

Dr. Scher's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Scher's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Scher is also affiliated with University Hospitals TriPoint Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Scher to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scher practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Scher's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Scher is licensed in Ohio.

CMS data shows 1,361 Medicare services from Dr. Scher across 16 procedure codes in 2024, for 141 Medicare patients. Medicare paid $82,545 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. Scher in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 74% have high cholesterol. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Scher's median patient age at 72, with 57% women.

In 2024, Dr. Scher wrote 83 Medicare Part D claims for 39 patients. 88% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $617 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

Dr. Scher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Scher, published from 2013 to 2021. 2016 was the busiest year, with 4. The most frequent topics are Carcinoma, Squamous Cell, Adenocarcinoma and Chemoradiotherapy. Dr. Scher has published most often in Int J Radiat Oncol Biol Phys. Dr. Scher's most frequent co-authors are Joseph Aisner, Sairam Balasubramanian, MD and Oren Cahlon, MD.

CMS Open Payments shows 1 general payment to Dr. Scher from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $28.